GeoVax Labs (GOVX)
(Delayed Data from NSDQ)
$0.72 USD
0.00 (0.61%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.72 0.00 (-0.65%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2025
Time: -- |
9/2025 | $-0.34 | 28.36% |
Earnings Summary
For their last quarter, GeoVax Labs (GOVX) reported earnings of -$0.35 per share, beating the Zacks Consensus Estimate of $-0.41 per share. This reflects a positive earnings surprise of 14.63%. Look out for GOVX's next earnings release expected on November 11, 2025. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year increase of 62.64%.
Earnings History
Price & Consensus
Zacks News for GOVX
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
GOVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
GOVX FAQs
GeoVax Labs Inc. (GOVX) has announced they will report their next quarter earnings on November 11, 2025. For the next earning release, we expect the company to report earnings of $-0.34 per share, reflecting a year-over-year increase of 62.64%.
GeoVax Labs Inc. has announced they will report their previous quarter earnings after the close of the market on November 11, 2025.
The Zacks Consensus Estimate for GeoVax Labs Inc. (GOVX) for the quarter ending in September 2025 is $-0.34 a share. We expect GeoVax Labs Inc. to miss by 28.36%.
In the earnings report for the quarter ending in June 2024, GeoVax Labs Inc. (GOVX) announced earnings of $-1.99 per share versus the Zacks Consensus Estimate of $-2.57 per share, representing a surprise of -22.57%.